APLS Prakiraan wutah bathi resik saben saham ing taun iki Apellis Corp

Simbol resmi perusahaan Apellis Pharmaceuticals (APLS)

Apellis Pharmaceuticals (APLS), a leader in the treatment of retinal atrophy, is currently countering the expansion of new market entrants through intensified marketing. The annual EPS growth rate reflects current dynamics, with the latest value recorded as -663.70. Management is striving for total niche dominance, while global sales scale the business, transforming costs into net margin growth.

Wutah bathi saben saham ing taun lumaku apellis.com (APLS): kanggo periode 04.07.2022 - 30.05.2026

Rincian analitis lan laporan data perusahaan Apellis Pharmaceuticals (APLS)

- nilai saham lan prakiraan konsensus rega:
Rega bursa Apellis Pharmaceuticals, Inc.|APLS - Bagan rega target
- data kapitalisasi pasar:
Kapitalisasi pasar Apellis Corp|APLS - Nilai Perusahaan
- data nilai buku modal saham:
Nilai Buku saben Saham Apellis Pharmaceuticals|APLS - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Aset Bersih apellis.com|APLS - Total Aset Perusahaan
- indikator beban utang lan likuiditas:
Utang marang Modal Apellis Pharmaceuticals|APLS - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas apellis.com|APLS - Utang perusahaan|Rasio utang marang kapitalisasi buku Apellis Corp|APLS - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Apellis Pharmaceuticals|Koefisien jangkoan perantara apellis.com
- rincian bathi lan kelipatan pasar:
APLS - Penghasilan resik|Penghasilan resik sing dikarepake Apellis Pharmaceuticals|APLS - Rasio rega marang bathi|Rasio rega marang bathi sing dikarepake Apellis Corp|APLS - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Apellis Corp|APLS - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Apellis Pharmaceuticals|APLS - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan apellis.com|APLS - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Apellis Pharmaceuticals
Analisis dhasar perusahaan:Apellis Pharmaceuticals, Inc., APLS
Produk mawa merek apellis.com

This indicator reflects the annual trend of net income per share, allowing for an assessment of real capital generation efficiency regardless of market volatility. By analyzing the annual EPS growth ratio, an investor determines business sustainability, which for Apellis Pharmaceuticals (APLS) is confirmed by the high margins of its patent-protected exclusive retinal treatment.

Pesaing langsung

Kacepetan wutah bathi saben saham ing taun lumaku Alcon Inc (ALC)|Wutah bathi saben saham ing taun lumaku Bausch + Lomb Corp|Glaukos Medical (GKOS) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku BLTE|Wutah bathi ing taun lumaku ocutx.com (OCUL)|Wutah bathi saben saham ing taun lumaku Harrow HROW|VRDN (Viridian Therapeutics Inc) - Dinamika bathi saben saham ing taun lumaku|LENZ Pharma - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Oaktree Specialty Lending|EyePoint Pharmaceuticals (EYPT) - Wutah bathi saben saham ing taun lumaku|KOD (kodiak.com) - Wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Aldeyra Therapeutics Inc.|Wutah bathi saben saham ing taun lumaku KALA|Wutah bathi ing taun lumaku IRD|Prakiraan wutah bathi resik saben saham ing taun iki okyopharma.com|Wutah bathi saben saham ing taun lumaku Adverum Biotechnologies, Inc. ADVM|Prakiraan wutah bathi resik saben saham ing taun iki outlooktherapeutics.com (OTLK)|CLSD: Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku NBY (NovaBay Pharmaceuticals)|kiorapharma.com (KPRX) - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham ing taun lumaku ALIM (Alimera Sciences, Inc.)|EYEN (Eyenovia Inc.) - Wutah bathi ing taun lumaku|GHSI: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku OCUP|Wutah bathi ing taun lumaku Opthea Ltd (OPT)